Stockscreener 앱 받기
2.78
1.67%
-0.06
Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스
Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance - MarketBeat
ANIX: Pivotal data from advanced cancer trials and fiscal discipline set the stage for a transformative 2026 - TradingView
Anixa reports promising survival data in ovarian cancer CAR-T trial - Investing.com Canada
Anixa reports promising survival data in ovarian cancer CAR-T trial By Investing.com - Investing.com South Africa
Anixa Biosciences (ANIX) Reports Positive Data in Ovarian Cancer CAR-T Trial - GuruFocus
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing - TipRanks
Anixa Biosciences reports encouraging patient survival observations in ovarian cancer CAR-T trial - marketscreener.com
Anixa Biosciences Reports Encouraging Patient Survival Observations In Ovarian Cancer Car-T Trial - TradingView
ANIX: Major dose escalation approved after strong survival and safety data in ovarian cancer CAR-T trial - TradingView
Anixa Biosciences Reports Encouraging Data in Ovarian Cancer CAR-T Trial - TradingView
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation - PR Newswire
EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues - Benzinga
Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Yahoo Finance
ANIX: Analyst Maintains "Buy" Rating and $10 Price Target | ANIX Stock News - GuruFocus
D. Boral Capital Reiterates "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization - BioSpace
Anixa Biosciences Secures United States Adopted Names Council Ap - GuruFocus
Anixa Biosciences (ANIX) CAR-T Therapy Receives USAN Approval - GuruFocus
Experimental ovarian cancer CAR-T earns official U.S. drug name - Stock Titan
Market Recap: Can Anixa Biosciences Inc keep up with sector leadersJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Director Arnold Baskies Acquires 10,000 Shares - MarketBeat
Anixa Biosciences director Baskies buys $30,400 in stock By Investing.com - Investing.com UK
Anixa Biosciences director Baskies buys $30,400 in stock - Investing.com
Anixa Biosciences receives Mexican patent for breast cancer vaccine By Investing.com - Investing.com Australia
Institution Moves: Does Anixa Biosciences Inc have declining or rising EPSTrade Exit Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology - The AI Journal
Anixa Biosciences rises after Mexico approves patent for breast cancer vaccine - TradingView
Anixa Biosciences (ANIX) Secures Mexican Patent for Breast Cance - GuruFocus
Anixa Biosciences receives Mexican patent for breast cancer vaccine - Investing.com
Dividend Watch: Is Anixa Biosciences Inc gaining market shareMarket Performance Recap & Community Verified Trade Signals - baoquankhu1.vn
New Highs: Whats Anixa Biosciences Incs historical returnQuarterly Risk Review & Technical Analysis for Trade Confirmation - baoquankhu1.vn
ANIX: Initiating Coverage; Anixa's T-Cell Innovations Show Breakthrough Potential in Solid Tumors - Smartkarma
Anixa Biosciences Inc (NASDAQ:ANIX) Short Interest Update - Defense World
Can Anixa Biosciences Inc. maintain its current growth rateEarnings Trend Report & Accurate Technical Buy Alerts - bollywoodhelpline.com
AI Stocks: What hedge funds are buying NUWECPI Data & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street Zen - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations - MarketBeat
Breakouts Watch: Will Anixa Biosciences Inc stock attract ESG investorsWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Anixa Biosciences : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com
Anixa Biosciences Inc SEC 10-K Report - TradingView — Track All Markets
Published on: 2026-01-11 17:33:32 - Улправда
ETF Watch: Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Улправда
Why Anixa Biosciences Inc. stock appeals to dividend seekersWeekly Earnings Recap & Stock Timing and Entry Methods - Улправда
What catalysts could drive Anixa Biosciences Inc. stock higherWeekly Trade Recap & Verified Entry Point Detection - Улправда
Why analysts upgrade Anixa Biosciences Inc. stockStock Buyback Updates & Low Risk Trading Portfolio - Улправда
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
0.13%
0.84%
자본화:
|
볼륨(24시간):